Coronavirus (COVID-19)
Read the latest updates relating to Coronavirus (COVID-19) and guidance for those who are clinically extremely vulnerable
Latest information
For information on what you should do if you test positive for COVID-19 please visit the NHS website.
The Joint Committee on Vaccination and Immunisation (JCVI) has confirmed its advice for a COVID-19 booster programme in autumn 2023. Eligible individuals include those who are aged over 6 months and immunosuppressed and any household contacts over 12 years old.
Further advice on the choice of vaccine products for use this autumn will be provided in due course. NHS England will confirm details on how and when eligible people can access the autumn booster vaccine in due course.
The Joint Committee on Vaccination and Immunisation (JCVI) has confirmed its advice for a 2023 spring COVID-19 booster programme for individuals over the age of 5 who are immunosuppressed.
Eligible individuals will be offered the vaccine around 6 months after their previous dose and NHS England will confirm operational details for the programme in due course.
If you are eligible for this, the NHS will contact you when it’s your turn to get vaccinated.
Appointments will be available from the National Booking Service shortly.
Amongst other groups those aged 5 years and over in a clinical risk group will be offered a booster of coronavirus (COVID-19) vaccine this autumn.
Appointments will be available from the National Booking Service shortly.
All of the available boosters provide good protection against severe illness from coronavirus (COVID-19).
Eligible adults in Wales have begun to be invited for their COVID-19 autumn booster.
The adapted COVID-19 vaccine made by Moderna targets two different coronavirus variants – the original virus from 2020 and the Omicron variant.
Covid-19 information
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus will experience mild to moderate illness and recover without requiring special treatment. However, some may become seriously ill and require medical attention.
Our understanding of COVID-19 has increased over the past years and together with the development of vaccines and effective treatments, progress has been made. In the UK deaths from COVID-19 have been significantly reduced.
COVID-19 vaccination is responsible for saving many lives. However, we know that some people with leukaemia and other blood cancers have a weakened immune system, meaning their immune response to the vaccine may not be as strong as others.
If you are a leukaemia patient and need more information about your COVID-19 risk, please seek advice from your healthcare professional, GP, Clinical Nurse Specialist or Consultant.
For information on what to do if you test positive for COVID-19 please visit the NHS website.
COVID-19 vaccines
For up-to-date advice please check the ‘latest information’ section above.
Further information and support
If you have a specific question or queries relating to coronavirus and leukaemia, please contact your medical team.
Blood Cancer UK and Leukaemia Care offer dedicated support lines for those affected by a blood cancer.
